Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2003
02/26/2003EP1284734A1 Protein kinase inhibitors
02/26/2003EP1284730A1 Aralkyl ester soft drugs
02/26/2003EP1140890B1 Chroman derivatives
02/26/2003EP0971901B1 Phthalazinones
02/26/2003EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors
02/26/2003EP0938483B1 Muscarinic antagonists
02/26/2003EP0850059B1 Pharmaceutical formulations containing darifenacin
02/26/2003EP0708763B1 Process for making hiv protease inhibitors
02/26/2003CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production
02/26/2003CN1399632A Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as active ingredient
02/26/2003CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
02/26/2003CN1399630A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments
02/26/2003CN1399515A Insecticidal and acaricidal agents
02/25/2003US6525202 Cyclic amine phenyl beta-3 adrenergic receptor agonists
02/25/2003US6525195 Method for obtaining polymorph a from doxazosine mesylate
02/25/2003US6525194 Chromene compound
02/25/2003US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists
02/25/2003US6525069 Such as N-(t-butyl)-N'-(2-((3-(4-fluorophenyl)methyl)piperi -dinyl)methyl)cyclohexyl)urea; prevention of asthma and other allergic diseases
02/25/2003US6525059 Substituted pyrazoles as p38 kinase inhibitors
02/25/2003US6525052 Compounds useful as reversible inhibitors of cysteine proteases
02/25/2003US6525051 For treating cytokine-induced hypotension, inflammatory bowel disease, cerebral ischemia, arthritis, adult respiratory distress syndrome, asthma
02/25/2003US6525046 Aromatic heterocyclic compounds as antiinflammatory agents
02/25/2003US6525042 Sulfonyl derivatives
02/25/2003US6525033 2', 3' dideoxynucleoside compounds; 2',3'-dideoxycytidine (beta -L-FddC), beta -L-2',3'-dideoxy-5-fluorocytidine (beta-L-ddC); beta-D-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-dioxolane
02/25/2003US6524347 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
02/25/2003CA2042243C N-acylated arylpyrroles useful as insecticidal, acaricidal, nematicidal and molluscicidal agents
02/21/2003WO2002016354A1 Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors
02/21/2003CA2420206A1 Chromenone derivatives and the use thereof for the treatment of diseases in connection with 5-hta1 receptors and/or dopamine d2 receptors
02/20/2003WO2003014255A1 Fluorescent diketopyrrolopyrrole analogues
02/20/2003WO2003014113A1 Novel benzopyran compounds and process for their preparation and use
02/20/2003WO2003014105A1 Bicyclic compound, production and use as hiv inhibitors
02/20/2003WO2003014103A1 Iodobenzopyran-4-one derivatives having fungicidal activity
02/20/2003WO2003014101A1 Hydroxamic acid derivatives
02/20/2003WO2003014092A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
02/20/2003WO2003014090A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003WO2003014083A1 Spiro compounds
02/20/2003WO2003014082A1 Cyclopenta ` b ! indole derivatives as spla2 inhibitors
02/20/2003WO2003014075A2 Novel gamma secretase inhibitors
02/20/2003WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003WO2003013531A1 Phenyl derivatives as factor xa inhibitors
02/20/2003WO2003013529A1 Paroxetine glycyrrhizinate
02/20/2003WO2003013528A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003WO2003013527A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003WO2003013526A1 Anticoagulant compounds
02/20/2003WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
02/20/2003WO2002102794A3 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
02/20/2003WO2002100829A3 Process for the preparation of paroxetine substantially free of alkoxy impurities
02/20/2003WO2002079182A3 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines
02/20/2003WO2002060874A8 Potassium channel inhibitors
02/20/2003WO2002049993A3 High affinity small molecule c5a receptor modulators
02/20/2003WO2002042295A3 Peptides as met-ap2 inhibitors
02/20/2003WO2001079187A8 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
02/20/2003US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives
02/20/2003US20030036654 Useful as mediators of protein-protein interactions
02/20/2003US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus
02/20/2003US20030036557 Heterocyclo-substituted imidazoles for the treatment of inflammation
02/20/2003US20030036552 Novel compounds
02/20/2003US20030036544 Pesticidal triazine-derivatives
02/20/2003US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
02/20/2003US20030036538 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest.
02/20/2003CA2607992A1 Bicyclic compound, production and use thereof
02/20/2003CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
02/20/2003CA2456599A1 Spiro compounds
02/20/2003CA2456291A1 Hydroxamic acid derivatives
02/20/2003CA2456175A1 Benzoquinone ansamycins
02/20/2003CA2455871A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists.
02/20/2003CA2455861A1 Sulfonamide derivatives as gamma secretase inhibitors
02/20/2003CA2455759A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
02/20/2003CA2451041A1 Iodobenzopyran-4-one derivatives having fungicidal activity
02/19/2003EP1284267A1 Triazole compounds having amide linkage
02/19/2003EP1284266A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
02/19/2003EP1283855A1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
02/19/2003EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
02/19/2003EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
02/19/2003EP0944603B1 Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
02/19/2003EP0920425B1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
02/19/2003EP0817786B1 Substituted tetronic acids useful for treating hiv and other retroviruses
02/19/2003EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
02/19/2003EP0690867B1 Taxanes having furyl or thienyl substituted side-chain
02/19/2003EP0639189B1 Pyridylpyrimidines, a method of preparing them, and their use in liquid-crystal mixtures
02/19/2003CN1398258A 4-hydroxycinnoline-3-carboxyamides as antiviral agents
02/19/2003CN1398256A Method for producing 5-aryl nicotinaldehydes
02/19/2003CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia
02/19/2003CN1397551A N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide
02/19/2003CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them
02/19/2003CN1101649C Herbicidal synergistic compsn. and method of controlling weeds
02/18/2003US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them
02/18/2003US6521650 Amines as pharmaceutical agents
02/18/2003US6521629 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia
02/18/2003US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
02/18/2003US6521623 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
02/18/2003US6521622 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
02/18/2003US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
02/18/2003US6521618 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease
02/18/2003US6521592 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
02/13/2003WO2003011872A1 Platelet adp receptor inhibitors
02/13/2003WO2003011857A1 Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom
02/13/2003WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011853A1 6-aryl-4-aminopicolinates and their use as herbicides
02/13/2003WO2003011815A1 Bicyclic heteroaromatic alanines